influenza-a-virus

Documents about influenza-a-virus

• A Study of Influenza Virus Vaccines in Children and Adults#906293ClinicalTrials.gov
• Occurrence of influenza antivirals and resistance development in influenza A viruses in aquatic environments: A risk assessment#1040243PLOS
• Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.#967072ClinicalTrials.gov
• Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers#890955ClinicalTrials.gov
• Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine#867649ClinicalTrials.gov
• Assessing spatial transmission risk of respiratory infectious diseases across cities of different socioeconomic tiers in China: A modelling study#385432PLOS
• Influenza Virus - A Multicenter Registry#892393ClinicalTrials.gov
• Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff.#833779ClinicalTrials.gov
• A Phase 2 Study to Evaluate Immune Responses of FluMist®#828303ClinicalTrials.gov
• Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years#867243ClinicalTrials.gov
• Safety and Immunogenicity of Live Attenuated Influenza H5N2#1031774ClinicalTrials.gov
• Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults#152480ClinicalTrials.gov
• Alveolar Macrophages Are Essential for Protection from Respiratory Failure and Associated Morbidity following Influenza Virus Infection#281612OpenAlex
• Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)#829475ClinicalTrials.gov
• Lactylation in influenza a virus infection: Current evidence, knowledge gaps, and future perspectives#651915Europe PMC
• Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults#893941ClinicalTrials.gov
• A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults#162533ClinicalTrials.gov
• A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children#467620ClinicalTrials.gov
• MAVS is important for antiviral defense against influenza A virus in a human respiratory epithelium model#255560PLOS
• Incidence of respiratory syncytial virus and influenza: A Danish nationwide cohort study#5093Europe PMC
• Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine#181601ClinicalTrials.gov
• Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza#885049ClinicalTrials.gov
• A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine#897789ClinicalTrials.gov
• Host Genetic Susceptibility to Avian Influenza A/H5N1#1032806ClinicalTrials.gov
• CFD Modeling of Influenza Virus Diffusion During Coughing and Breathing in A Ventilated Room#940251Journal of Thermal Engineering
• Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study#141089ClinicalTrials.gov
• Influenza situation in the Eastern Mediterranean Region: W33/2021 (from 15/08/2021 to 21/08/2021): source of data: EMFLU Network and FLUMART#435424WHO IRIS
• H5N1 Vaccine Study in Japanese Adults#834783ClinicalTrials.gov
• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth#903226ClinicalTrials.gov
• A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above#158053ClinicalTrials.gov
• Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)#852943ClinicalTrials.gov
• Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses#876921ClinicalTrials.gov
• A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months#895475ClinicalTrials.gov
• Follow-up of Immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers After 6 Months#840249ClinicalTrials.gov
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children#346961ClinicalTrials.gov
• Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population#979880ClinicalTrials.gov
• A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza#890487ClinicalTrials.gov
• Data Sheet 1_Methods for detecting highly pathogenic avian influenza H5N1 virus in dairy processing environments.docx#253478Figshare
• Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults#195406ClinicalTrials.gov
• A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults#872339ClinicalTrials.gov
• Predictors of fatality in influenza A virus subtype infections among inpatients in the 2015–2016 season#955473Koc University Digital Collections
• Study of novel pro-viral activities of non-structural protein 1 (NS1) of influenza A virus#242999Repositorio Institucional de la Universidad de Burgos (RIUBU)
• Weight-Loss Cutoff for Mortality in Mice Impacts the Results From Combination Drug Therapy for an Influenza A H1N1pdm Virus Infection#224099DigitalCommons@USU
• Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults#833380ClinicalTrials.gov
• A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season#915944ClinicalTrials.gov
• Influenza A VIRus and Destabilization of Atherosclerotic Carotid Plaques#842115ClinicalTrials.gov
• Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza#160187ClinicalTrials.gov
• Small molecule inhibition of the mitochondrial lipid transfer protein STARD7 attenuates influenza viral replication#686612PLOS
• Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects#1046316ClinicalTrials.gov
• Genetic and antigenic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness = Caractéristiques génétiques et antigéniques des virus grippaux A zoonotiques et mise au point de virus vaccinaux candidats dans le cadre de la préparation aux pandémies#341847WHO IRIS